Oculis Holding AG(OCS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
OCS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Oculis Holding AG (OCS), a Healthcare sector company. OCS is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Top institutional holders of OCS by reported 13-F value include EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, abrdn plc, based on the most recent SEC filings. OCS trades on the Nasdaq exchange and files with the SEC under CIK 1953530. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OCS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Oculis Holding AG directly from SEC EDGAR.
Get alerted when OCS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Oculis Holding AG including:
Top Institutional Holders of OCS
EQT Fund Management S.a r.l.
$156.9M5,900,294 shGildi - lifeyrissjodur
$64.3M2,430,401 shabrdn plc
$46.5M1,746,946 shPivotal bioVenture Partners Investment Advisor LLC
$44.7M1,680,283 shWELLINGTON MANAGEMENT GROUP LLP
$35.8M1,345,728 shMILLENNIUM MANAGEMENT LLC
$24.3M913,034 shADAGE CAPITAL PARTNERS GP, L.L.C.
$22.2M833,209 shSR ONE CAPITAL MANAGEMENT, LP
$17.0M641,022 shSaturn V Capital Management LP
$13.7M516,761 shPERCEPTIVE ADVISORS LLC
$13.1M493,827 sh
| Fund | Value | Shares |
|---|---|---|
| EQT Fund Management S.a r.l. | $156.9M | 5,900,294 |
| Gildi - lifeyrissjodur | $64.3M | 2,430,401 |
| abrdn plc | $46.5M | 1,746,946 |
| Pivotal bioVenture Partners Investment Advisor LLC | $44.7M | 1,680,283 |
| WELLINGTON MANAGEMENT GROUP LLP | $35.8M | 1,345,728 |
| MILLENNIUM MANAGEMENT LLC | $24.3M | 913,034 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22.2M | 833,209 |
| SR ONE CAPITAL MANAGEMENT, LP | $17.0M | 641,022 |
| Saturn V Capital Management LP | $13.7M | 516,761 |
| PERCEPTIVE ADVISORS LLC | $13.1M | 493,827 |
More Healthcare Companies
View all Healthcare →Put OCS on your watchlist
Track score changes the day Oculis Holding AG files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is OCS a good stock to buy?
13F Pro's AI-powered analysis of Oculis Holding AG (OCS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OCS are available on the OCS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own OCS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OCS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Oculis Holding AG's investment landscape.